Merck & Co. Inc. held its Annual Meeting of Shareholders on May 27, 2025. During the meeting, several proposals were voted on. The election of the Board of Directors was approved. The ratification of the appointment of the Company's independent registered public accounting firm for 2025 was also approved. However, a shareholder proposal regarding a human rights impact assessment was not approved.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.